Oncology Intelligence Digest August 14, 2026 The FDA granted approval to Bristol Myers Squibb’s Zenbexus (iberdomide) in multiple…
Oncology Intelligence Membership Required
You must be a Oncology Intelligence member to access this content.
Already a member? Log in here